Description of Business	6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]
Description of Business	Note 1. Description of Business *Nature of Business* SkyAI, Inc. (“SkyAI” or the “Company”) was founded as a medical device company. On April 13, 2022, the Company’s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company received net proceeds of $14.2 million on April 19, 2022. Through October 6, 2025, the Company’s activities included the design, manufacture and distribution of a portfolio of syringes and drug related delivery systems. On October 6, 2025, the Company entered into definitive agreements, including a bill of sale, assignment and assumption agreement providing for the transfer by the Company of certain assets, and a contract for the transfer of business share providing for the assignment by the Company of all of the Company’s right, title and interest in and to the issued and outstanding shares of Safegard Medical Kft, the Hungarian subsidiary, which is reflected in the accompanying financial statements as a discontinued operation. As of October 6, 2025, with the ownership transfer of Safegard Medical Kft complete, the Company discontinued all design and manufacturing endeavors to focus instead solely on marketing and distribution. On August 24, 2025, the Company adopted a digital commodity treasury strategy focused on accumulating Solana (“SOL”), the native digital commodity of the Solana blockchain. On May 26, 2026, the Company filed a Certificate of Amendment to its articles of incorporation to change the name of the Company to SkyAI, Inc. and effectuate the name change with the Nevada Secretary of State. On May 28, 2026, the Company’s common stock ceased trading under the ticker symbol “STSS” and began trading under the new ticker symbol “SKYA,” and its warrants ceased trading under the ticker symbol “STSSW” and began trading under the new ticker symbol “SKYAW.” On May 27, 2026, the Company announced a strategic transformation of its business, reflecting a shift from its legacy operations to the development of a technology-driven financial platform and the establishment of an international operational headquarters in Hong Kong. The accompanying condensed consolidated financial statements include the accounts of SkyAI, Inc. and its wholly owned subsidiaries, SOL Equity Limited, and Axis Global Tech Limited (f/k/a Sol Equity HK Limited), collectively referred to as the “Company.” All intercompany transactions and balances have been eliminated.

Description of Business

6 Months Ended

Jun. 30, 2026

Note 1. Description of Business

Nature of Business

SkyAI, Inc. (“SkyAI” or the “Company”) was founded as a medical device company. On April 13, 2022, the Company’s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company received net proceeds of $14.2 million on April 19, 2022. Through October 6, 2025, the Company’s activities included the design, manufacture and distribution of a portfolio of syringes and drug related delivery systems.

On October 6, 2025, the Company entered into definitive agreements, including a bill of sale, assignment and assumption agreement providing for the transfer by the Company of certain assets, and a contract for the transfer of business share providing for the assignment by the Company of all of the Company’s right, title and interest in and to the issued and outstanding shares of Safegard Medical Kft, the Hungarian subsidiary, which is reflected in the accompanying financial statements as a discontinued operation. As of October 6, 2025, with the ownership transfer of Safegard Medical Kft complete, the Company discontinued all design and manufacturing endeavors to focus instead solely on marketing and distribution.

On August 24, 2025, the Company adopted a digital commodity treasury strategy focused on accumulating Solana (“SOL”), the native digital commodity of the Solana blockchain.

On May 26, 2026, the Company filed a Certificate of Amendment to its articles of incorporation to change the name of the Company to SkyAI, Inc. and effectuate the name change with the Nevada Secretary of State. On May 28, 2026, the Company’s common stock ceased trading under the ticker symbol “STSS” and began trading under the new ticker symbol “SKYA,” and its warrants ceased trading under the ticker symbol “STSSW” and began trading under the new ticker symbol “SKYAW.”

On May 27, 2026, the Company announced a strategic transformation of its business, reflecting a shift from its legacy operations to the development of a technology-driven financial platform and the establishment of an international operational headquarters in Hong Kong.

The accompanying condensed consolidated financial statements include the accounts of SkyAI, Inc. and its wholly owned subsidiaries, SOL Equity Limited, and Axis Global Tech Limited (f/k/a Sol Equity HK Limited), collectively referred to as the “Company.” All intercompany transactions and balances have been eliminated.